Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 36640 | 77 | 25.0 | 31% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
| 587 | 3 | DECOMPRESSION SICKNESS//HIGH ALTITUDE MEDICINE & BIOLOGY//ACUTE MOUNTAIN SICKNESS | 15311 |
| 3113 | 2 | JOURNAL OF TRAVEL MEDICINE//HYDROTROPY//HYDROTROPES | 2303 |
| 36640 | 1 | CAS 56583 43 8//CAS 17692 39 6//2 HYDROXYPROPL BETA CYCLODEXTRIN | 77 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | CAS 56583 43 8 | authKW | 1189702 | 4% | 100% | 3 |
| 2 | CAS 17692 39 6 | authKW | 793134 | 3% | 100% | 2 |
| 3 | 2 HYDROXYPROPL BETA CYCLODEXTRIN | authKW | 396567 | 1% | 100% | 1 |
| 4 | CAS 59 46 1 | authKW | 396567 | 1% | 100% | 1 |
| 5 | CLIN PHARMACOL DRUG METAB PHARMOCOKINET | address | 396567 | 1% | 100% | 1 |
| 6 | FOMOCAINE ALKYLMORPHOLINE DERIVATIVES ENANTIOMERS | authKW | 396567 | 1% | 100% | 1 |
| 7 | FOMOCAINE ALKYLMORPHOLINE DERIVATIVES LOCAL ANAESTHESIA RAT STRUCTURE ACTIVITY RELATIONSHIPS TOXICITY | authKW | 396567 | 1% | 100% | 1 |
| 8 | FOMOCAINE CHIRALIC DERIVATIVES LOCAL ANAESTHETIC EFFECTIVITY METABOLITES RAT TOXICITY | authKW | 396567 | 1% | 100% | 1 |
| 9 | FOMOCAINE DERIVATIVES RAT TOXICITY | authKW | 396567 | 1% | 100% | 1 |
| 10 | FOMOCAINE METABOLITES PHARMACOLOGY PHYSICOCHEMICAL PROPERTIES TOXICOLOGY | authKW | 396567 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 1592 | 82% | 0% | 63 |
| 2 | Chemistry, Medicinal | 1076 | 35% | 0% | 27 |
| 3 | Chemistry, Multidisciplinary | 533 | 53% | 0% | 41 |
| 4 | Toxicology | 29 | 6% | 0% | 5 |
| 5 | Mycology | 6 | 1% | 0% | 1 |
| 6 | Pathology | 3 | 3% | 0% | 2 |
| 7 | Social Sciences, Interdisciplinary | 3 | 1% | 0% | 1 |
| 8 | Medical Laboratory Technology | 3 | 1% | 0% | 1 |
| 9 | Gastroenterology & Hepatology | 3 | 3% | 0% | 2 |
| 10 | Developmental Biology | 2 | 1% | 0% | 1 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CLIN PHARMACOL DRUG METAB PHARMOCOKINET | 396567 | 1% | 100% | 1 |
| 2 | HAWAII CANC | 396567 | 1% | 100% | 1 |
| 3 | COMPUTAT SYST MEDBIOMOL MED | 198283 | 1% | 50% | 1 |
| 4 | HOSP OLOMOUC | 44061 | 1% | 11% | 1 |
| 5 | PHARMACEUT SERV 111 HONJO | 44061 | 1% | 11% | 1 |
| 6 | CHINESE MED THER Y SYST BIOL | 32369 | 3% | 4% | 2 |
| 7 | E SHANGHAI MUNICIPAL EDUC COMM | 23326 | 1% | 6% | 1 |
| 8 | LEHRSTUHL PHARMAZEUT CHEM | 11329 | 1% | 3% | 1 |
| 9 | LIFE NANOPHARMACEUT SCI | 4315 | 4% | 0% | 3 |
| 10 | CANC EPIDEMIOL PROGRAM | 3932 | 3% | 0% | 2 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | PHARMACEUTICA ACTA HELVETIAE | 251594 | 27% | 3% | 21 |
| 2 | ARZNEIMITTELFORSCHUNG-DRUG RESEARCH | 7902 | 6% | 0% | 5 |
| 3 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 3247 | 8% | 0% | 6 |
| 4 | CURRENT CONTENTS/CLINICAL PRACTICE | 3121 | 1% | 1% | 1 |
| 5 | ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH | 3018 | 5% | 0% | 4 |
| 6 | PHARMAZIE | 2183 | 9% | 0% | 7 |
| 7 | JOURNAL OF DIARRHOEAL DISEASES RESEARCH | 1650 | 1% | 0% | 1 |
| 8 | GUT PATHOGENS | 1425 | 1% | 0% | 1 |
| 9 | ARCHIV DER PHARMAZIE | 826 | 4% | 0% | 3 |
| 10 | RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY | 691 | 3% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | LUPP, A , KARGE, E , DAHSE, T , GLASSL, P , JUNG, B , LISTING, M , SEELING, A , WANGE, J , WENNEK-KLOSE, J , OELSCHLAGER, H , ET AL (2007) A SYNOPSIS ON DIFFERENT HOMOLOGOUS SERIES OF FOMOCAINE DERIVATIVES - IN VITRO INTERACTIONS WITH THE CYTOCHROME P450 SYSTEM, TOXICITY, AND LOCAL ANAESTHETIC EFFECTS IN RATS - PART III.ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH. VOL. 57. ISSUE 11. P. 685-688 | 10 | 56% | 0 |
| 2 | FLECK, C , KARGE, E , LOY, S , WENNEK-KLOSE, J , LISTING, M , OELSCHLAGER, H , (2003) LOCAL ANAESTHETIC EFFECTS AND TOXICITY OF SEVEN NEW DIETHANOLAMINE AND MORPHOLINE DERIVATIVES OF FOMOCAINE - TESTING IN RATS COMPARED WITH PROCAINE AND TETRACAINE.ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH. VOL. 53. ISSUE 3. P. 221 -228 | 6 | 75% | 6 |
| 3 | FLECK, C , WENNEK-KLOSE, J , WANGE, J , OELSCHLAGER, H , (2004) EFFECTS AND TOXICITY OF NEW FOMOCAINE DERIVATIVES AND OF 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN INCLUSION COMPOUNDS IN RATS.ARZNEIMITTELFORSCHUNG-DRUG RESEARCH. VOL. 54. ISSUE 5. P. 265 -274 | 7 | 54% | 4 |
| 4 | LUPP, A , KARGE, E , WANGE, J , EISENTRAUT, C , ZWENZNER, T , OELSCHLAGER, H , FLECK, C , (2006) IN VITRO INTERACTIONS WITH THE CYTOCHROME P450 SYSTEM, TOXICITY, AND LOCAL ANAESTHETIC EFFECTS OF FOMOCAINE ALKYLMORPHOLINE DERIVATIVES IN RATS - DETERMINATION OF STRUCTURE-ACTIVITY RELATIONSHIPS.ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH. VOL. 56. ISSUE 1. P. 1-11 | 7 | 50% | 3 |
| 5 | DAHSE, T , WENNEK-KLOSE, J , LISTING, M , FLECK, C , OELSCHLAGER, H , (2006) IN VITRO INVESTIGATIONS OF PHASE I METABOLISM OF THE FOMOCAINE DERIVATIVE OE 9000 WITH PIG LIVER HOMOGENATES.PHARMAZIE. VOL. 61. ISSUE 11. P. 943 -951 | 5 | 56% | 1 |
| 6 | THOMA, K , VONSTEIN, C , (1990) INFLUENCING THE RELEASE OF ANTIDEPRESSANT, SEDATIVE AND ANTIPSYCHOTIC AGENTS IN COLLOIDAL SOLUTIONS BY CHANGING THEIR ASSOCIATION PROPERTIES .1. EFFECTS OF CHEMICAL-STRUCTURE AND PHYSICOCHEMICAL PROPERTIES ON MIXED MICELLE FORMATION WITH NON-IONIC SURFACTANTS.PHARMACEUTICA ACTA HELVETIAE. VOL. 65. ISSUE 1. P. 20-27 | 5 | 100% | 1 |
| 7 | THOMA, K , VONSTEIN, C , (1990) INFLUENCE OF CHANGES IN THE ASSOCIATION PROPERTIES OF PSYCHOPHARMACEUTICALS ON THEIR RELEASE IN COLLOID SOLUTIONS .4. INFLUENCE OF CHEMICAL-STRUCTURE AND ENVIRONMENTAL-CONDITIONS ON THE INCREASE IN CRITICAL MICELLE FORMATION CONCENTRATION AND ON THE REDUCTION OF MICELLAR WEIGHT BY HYDROTROPIC SUBSTANCES.PHARMACEUTICA ACTA HELVETIAE. VOL. 65. ISSUE 4. P. 98-104 | 5 | 83% | 0 |
| 8 | LUPP, A , WANGE, J , OELSCHLAGER, H , FLECK, C , (2006) PHARMACOLOGICAL AND TOXICOLOGICAL TESTING OF THE ENANTIOMERS OF TWO CHIRAL FOMOCAINE ALKYLMORPHOLINE DERIVATIVES IN COMPARISON TO THEIR IN VITRO INTERACTIONS ON DRUG METABOLISM IN RATS.ARZNEIMITTELFORSCHUNG-DRUG RESEARCH. VOL. 56. ISSUE 6. P. 369-376 | 6 | 38% | 1 |
| 9 | THOMA, K , KASPER, FR , (1988) COLLOID ASSOCIATION AND BIOAVAILABILITY OF LOCAL-ANESTHETICS .8. THE RELATIONSHIP BETWEEN PHYSICOCHEMICAL PROPERTIES AND FORMATION OF MIXED MICELLES.PHARMACEUTICA ACTA HELVETIAE. VOL. 63. ISSUE 6. P. 160-163 | 4 | 100% | 1 |
| 10 | FLECK, C , KAMENA, M , TSCHRITTER, L , KERSTEN, L , SEELING, A , GLASSL, P , OELSCHLAGER, H , (2001) LOCAL ANAESTHETIC EFFECTIVITY AND TOXICITY OF FOMOCAINE, FIVE N-FREE FOMOCAINE METABOLITES AND TWO CHIRALIC FOMOCAINE DERIVATIVES IN RATS COMPARED WITH PROCAINE.ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH. VOL. 51. ISSUE 6. P. 451-458 | 4 | 57% | 2 |
Classes with closest relation at Level 1 |